Comparing incretin-based therapies. Evaluating GLP-1 agonists and DPP-4 inhibitors for type 2 diabetes mellitus.

Advance for NPs & PAs

Volumn 1, Issue 2, 2010, Pages 38-44

  Urquhart, B Scott ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1; INCRETIN;

CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; PHYSICIAN ASSISTANT; REVIEW; STATISTICS;

BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; NURSE PRACTITIONERS; PHYSICIAN ASSISTANTS;

EID: 79952268070     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)